Tango Therapeutics Inc share price logo

Tango Therapeutics Inc Share Price

NASDAQ: TNGX

Mid Cap

$18.95

-0.48

(-2.45%)

as on

Tango Therapeutics Inc Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's High

    $18.95
    $19.91

    5.07%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.03
    $19.81
    downward going graph

    94.56%

    Downside

    4.51%

    Upside

    downward going graph

Tango Therapeutics Inc share price movements today

Previous Close
$19.42
Open
$19.04
Volume
2.6M
Day's Low - High
$18.95 - $19.91
52 Week Low - High
$1.03 - $19.81

Tango Therapeutics Inc Historical Returns

1 Month Return
+ 52.55 %
3 Month Return
+ 127.67 %
1 Year Return
+ 1003.41 %
3 Year Return
+ 377.15 %
5 Year Return
0 %

Tango Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tango Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8B

EPS (TTM)

-1.3189

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.23

Industry PE ratio

0

PEG Ratio

0

EBITDA

-109.0M

Revenue (TTM)

62.4M

Profit Margin

-162.85%

Return On Equity TTM

-37.24%

Tango Therapeutics Inc Stock Valuation

Track how Tango Therapeutics Inc P/E has moved over time to understand its valuation trends.

Tango Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-28.97x)

September 30, 2021

Industry (0.00x)

March 23, 2026

Today (-10.23x)

March 23, 2026

Highest (-1.87x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -10.23x

Tango Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tango Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Tango Therapeutics Inc image
Tango Therapeutics Inc
BUY$2.8BNA-10.23-162.85%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Tango Therapeutics Inc Stock including INR - Dollar returns

The Tango Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Tango Therapeutics Inc investment value today

Current value as on today

₹10,86,624

Returns

₹9,86,624

(+986.62%)

Returns from Tango Therapeutics Inc Stock

₹9,76,705 (+976.7%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Tango Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Tango Therapeutics Inc. Average target price of $19.67

Tango Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tango Therapeutics Inc.

What analysts predicted

3.66%UPSIDE

Target Price

$19.67

Current Price

$18.95

Analyzed by

14 Analysts

Target

$19.67

Tango Therapeutics Inc target price $19.67, a slight upside of 3.66% compared to current price of $18.95. According to 14 analysts rating.

Tango Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Tango Therapeutics Inc Stock has increased by 96% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:96% versus previous 30 day period

Tango Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10
5
6
19
11
4
5
3
53
-
Gross Profit
10
5
6
19
11
4
5
2
53
0
Operating Income
-25
-35
-42
-29
-32
-40
-42
-40
14
-41
EBITDA
-21
-34
-41
-28
-32
-40
-41
-38
16
-41
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-22
-30
-37
-25
-29
-37
-39
-38
15
-38
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-22
-30
-37
-25
-29
-37
-39
-38
15
-38
Net Profit Margin
-207.45%
-566.43%
-585.91%
-128.56%
-251.29%
-914.99%
-739.54%
-1221.41%
29.52%
0.00%

Tango Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
24
7
37
24
36
42
62
Gross Profit
-7
6
37
24
36
42
60
Operating Income
-15
-52
-58
-111
-114
-145
-111
EBITDA
-14
-50
-57
-109
-111
-143
-109
Interest Expense
-
-
1
2
-
-
-
Depreciation
-
0
0
1
2
2
2
Income Before Tax
-14
-51
-57
-108
-101
-130
-101
Income Tax Expense
-
0
0
0
0
0
0
Net Income
-14
-51
-58
-108
-101
-130
-101
Net Profit Margin
-57.18%
-678.84%
-157.21%
-435.14%
-278.54%
-309.73%
-162.85%

Tango Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-30
-37
-25
-29
-37
-39
-38
15
-38
Operating Cash Flow
-27
-37
-23
-33
-36
-41
-36
-30
-29
Investing Cash Flow
33
-11
12
32
52
30
16
47
-135
Financing Cash Flow
1
42
1
2
0
0
0
2
219
Change in Cash
7
-6
-9
1
16
-11
-19
19
53

Tango Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-51
-58
-108
-101
-130
-101
Operating Cash Flow
70
-59
-109
-117
-131
-138
Investing Cash Flow
-145
-183
26
41
86
-40
Financing Cash Flow
80
357
1
82
47
222
Change in Cash
5
114
-81
5
2
42

Global Institutional Holdings in Tango Therapeutics Inc

Funds
Holdings
Suvretta Capital Management, LLC
1.87%
RA Capital Management, LLC
1.8%
Point72 Asset Management, L.P.
2.05%
Geode Capital Management, LLC
1.79%
Geode Capital Management, LLC
1.59%
See all

Insights on Tango Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TNGX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TNGX stock has moved up by 127.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.18M → 53.81M (in $), with an average increase of 94.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TNGX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 15.88M → -38.74M (in $), with an average decrease of 344.0% per quarter

About Tango Therapeutics Inc

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. tango therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. these include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. what fuels each of tango’s programs is an increasingly sophisticated ability to util
OrganisationTango Therapeutics Inc
Headquarters201 Brookline Avenue, Boston, MA, United States, 02215
CEODr. Malte Peters M.D.
E-voting on sharesClick here to vote

Key Management of Tango Therapeutics Inc

Name

Title

Dr. Michael Palmieri Ph.D.

Chief Technical Operations Officer

Dr. Malte Peters M.D.

President, CEO & Director

Ms. Daniella Beckman CPA

Chief Financial Officer

Prof. Alan Ashworth FRS, Ph.D.

Founder & Member of Scientific Advisory Board

Dr. William G. Kaelin Jr., M.D.

Founder & Member of Scientific Advisory Board

Ms. Elizabeth Pingpank Hickin

VP of IR & Corporate Communications

Dr. Barbara L. Weber M.D.

Founder & Executive Chair

Dr. Adam S. Crystal M.D., Ph.D.

President of Research & Development

Dr. Antoni Ribas M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Mr. Jannik N. Andersen Ph.D.

Chief Scientific Officer

FAQs

What is Tango Therapeutics Inc share price today?

Tango Therapeutics Inc share price today is $18.95 as on at the close of the market. Tango Therapeutics Inc share today touched a day high of $19.91 and a low of $18.95.

What is the 52 week high and 52 week low for Tango Therapeutics Inc share?

Tango Therapeutics Inc share touched a 52 week high of $19.81 on and a 52 week low of $1.03 on . Tango Therapeutics Inc stock price today i.e. is closed at $18.95,which is 4.32% down from its 52 week high and 1739.81% up from its 52 week low.

What is Tango Therapeutics Inc's market capitalisation today?

Tango Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Tango Therapeutics Inc Stock (TNGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tango Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tango Therapeutics Inc Shares that will get you 0.0792 shares as per Tango Therapeutics Inc share price of $18.95 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Tango Therapeutics Inc Stock (TNGX) from India?

Indian investors can start investing in Tango Therapeutics Inc (TNGX) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Tango Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Tango Therapeutics Inc share’s latest price of $18.95 as on March 24, 2026 at 1:29 am IST, you will get 0.5277 shares of Tango Therapeutics Inc. Learn more about fractional shares .